About us
History
Techops GmbH founded by Dr. Walter Kittl in 2016.
Clients
- Stock listed and private companies (CDMOs and pharmaceutical companies)
- Private Equity
Assignments
- Board member
- Senior adviser
- Interim COO of large global CDMO (2000 FTE)
- Interim COO of startup biological company
- Interim MD of high potent drug product company (300 FTE)
- Due diligences
- CDMO selections
- CDMO consulting improving EBITDA
- Capital investment consulting
Expertise
An extended and successful history in Biotech and Small Molecules is the basis for competent consulting in these industries.
Continuous improvement is essential in our industry. Techops GmbH is familiar with the relevant tools and capitalizes on a treasure trove of experience.
Selection of the right CDMO!
More EBITDA together with Techops GmbH!
Techops GmbH can rely on more than 35 years of professional and hands-on experience in the management of small and large organizations. Such organizations are located in Switzerland, EU, USA and China. The leadership challenge includes growth on site, building and starting up new sites, restructuring and transformation.
Strong track record regarding significant EBITDA increases!
Techops GmbH provides broad experience in a wide range of projects. The scope comprises capital projects ($1 mio to $150 mio), process improvements and business excellence projects within technical operations. The assignments include project design, project management, project controlling and steering committees.
Techops GmbH will support you in increasing your EBITDA of multi-purpose plants and entire sites significantly applying its wealth of experience in this field.
If you need to gain efficiency and/or to reduce your total cost of non quality Techops GmbH will be your competent partner.
The proper management of corrective and preventive actions (CAPAs) is key for manufacturing controlled by ISO and/or GMP. Techops GmbH can tap into many very successful initiatives and projects in the area of handling of deviations, root cause analysis and avoidance of over-dues.
Successful transfers of chemical and/or biotech processes are the foundation of CDMOs. Techops GmbH has comprehensive experience in such transfers from the lab to production, from plant to plant on the same site and from one site to another location globally.
Techops GmbH has detailed know-how about technologies, equipment and processes in the area of Fine Chemical and Life Sciences industries. Furthermore Techops GmbH can rely on profound knowledge about safety, security and environmental requirements and state of the art in such industries. A thorough understanding of GMP and compliance completes the range of experience.
Techops GmbH can tap into an extensive understanding of the relevant industry. New asset strategies require different actions depending on the current situation. Such actions may range from closing and/or restructuring to adding new technologies and/or growing regionally and/or globally. Both, organic growth and growth by acquisitions, will be addressed.